Curative Biosciences Announces New Line of THC-Free CBD Softgels

MIAMI, May 05, 2020 (GLOBE NEWSWIRE) — Curative Biosciences, Inc., (CBDX) (“Curative”) announced today the launch of its new line of Full-Spectrum CBD Oil Softgels.  Curative’s pharmaceutical grade hemp-derived CBD Softgels contain 10mg and 25mg per softgel and will be offered in bottles containing 300mg, 600mg, 750mg, and 1,500mg of CBD. 
Curative’s CBD Oil Softgels are whole-plant extracts containing a full-spectrum of naturally occurring synergistic cannabinoids and terpenes.  The product benefits include:Zero THCFully AbsorbableOptimum BioavailabilityFull-Spectrum CannabinoidsGMP/NSF ManufacturedLab-tested for Quality and PurityMade in the USAThe introduction of this new of line CBD Oil Softgels allows Curative Biosciences to meet the growing demand for CBD oil products in the United States, Canada and 60+ other countries.  BDS Analytics and ArcView Market Research estimates the Cannabidiol (CBD) market will experience 49% compounded annual growth between 2018 to 2024 and grow to over $20 billion annual sales.“Curative’s CBD Softgels are created with a patent-pending water-soluble formulation of CBD and proprietary blend of phytocannabinoids and naturally present terpenes.  Our CBD oil products are made in the USA from naturally developed genetic strains of US grown Phytocannabinoid-Rich industrial hemp to provide our health-conscious customers a safe and regulated product,” stated Katherine West, Curative’s Chief Operating Officer.Hemp-derived CBD has been shown to be effective in supporting a wide range of medical conditions, including sleep disorders, anxiety, arthritic and muscular discomfort, high blood pressure, and various skin conditions.  Curative’s CBD products can be viewed at Curative’s website DISCLAIMER
These statements have not been evaluated by the Food and Drug Administration.  These products are not intended to diagnose, treat, cure, or prevent any disease.
About Curative Biosciences, Inc.
Curative Biosciences (CBDX), is creating a new category in the health industry by translating advances in science and technology into effective, scientifically sound health products available to people in their everyday lives. We are developing a portfolio of products with compelling compounds found in nature that offer an opportunity for our customers to proactively support their health. The company’s website is
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.